John E. Bishop

Insider Reports History

Entity
Individual
Location
675 West Kendall Street, Cambridge, MA
Signature
/s/ Jason Cavalier, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John E. Bishop:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyra Therapeutics, Inc. Chief Technology Officer Stock Options 200K Jan 30, 2024 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Technology Officer Common Stock 0 $5.05 Oct 14, 2022 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Technology Officer Stock Option (Right to Buy) 0 Oct 14, 2022 Direct

Insider Reports Filed by John E. Bishop

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYRA Lyra Therapeutics, Inc. Jan 30, 2024 1 $0 4 Feb 1, 2024 Chief Technology Officer
LYRA Lyra Therapeutics, Inc. Feb 27, 2023 1 $0 4 Feb 28, 2023 Chief Technology Officer
LYRA Lyra Therapeutics, Inc. Feb 27, 2023 0 $0 3 Feb 28, 2023 Chief Technology Officer
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 3 $0 4 Oct 14, 2022 SVP, Chief Technology Officer
FMTX Forma Therapeutics Holdings, Inc. Feb 28, 2022 2 $0 4 Mar 2, 2022 SVP, Chief Technology Officer
FMTX Forma Therapeutics Holdings, Inc. Jun 14, 2021 2 $0 4 Jun 15, 2021 Chief Technology Officer
FMTX Forma Therapeutics Holdings, Inc. Jun 14, 2021 0 $0 3 Jun 15, 2021 Chief Technology Officer